Business Information
The group's principal activity is to develop proprietary products that improve animal health and productivity in the dairy and beef industry. In addition, to this the group also conducts a phase ii clinical trail of diffgam(tm) bovine anti-clostridium difficile immunoglobulins, a human application of its milk derived passive antibody technology. The group has customers in Canada, Australia, New Zealand and Europe. The trademarks of the group are first defense(R), crypto-scan(R), tip-test(R), mastik(R), rpt(tm), accufirm(tm) and rjt(tm).
|
|
Name |
Title
|
Email
|
| Joseph Crabb | Dir., VP, Chief Scientific Officer | N/A | | David Tomsche | Dir. | N/A | | Jonathan Rothschild | Dir. | N/A | | Linda Rhodes | Dir. | N/A | | Michael Brigham | Dir., CEO, Pres. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 4,801 | 647 | | 2005 | 4,983 | 708 | | 2004 | 3,696 | 144
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
